Ozempic for Weight Loss
Novo Nordisk's weekly injection for type 2 diabetes. Ozempic is the most widely prescribed GLP-1 in the world, and the same drug (semaglutide) that is sold as Wegovy for weight loss.
Reviewed by GlobalGLP1 editorial team • Last reviewed March 2026 • Sources: FDA prescribing information, peer-reviewed clinical trials
Overview
Ozempic is a once-weekly injection from Novo Nordisk that was FDA-approved in 2017 to treat type 2 diabetes. It works by mimicking a natural hormone called GLP-1, which helps the pancreas release insulin after meals, slows how fast your stomach empties, and reduces appetite. Ozempic uses the same active ingredient (semaglutide) as Wegovy, but Wegovy is the version specifically approved for weight loss at a higher dose. Ozempic is FDA-approved only for type 2 diabetes in adults, and to reduce the risk of heart attack, stroke, and cardiovascular death in adults with both type 2 diabetes and heart disease. It is not approved for weight loss, but some doctors prescribe it off-label for that reason and insurance rarely covers off-label use.
How Ozempic Works
Ozempic works by copying a hormone your body already makes called GLP-1. This hormone helps the pancreas release insulin after meals, slows down how fast food leaves your stomach, and reduces appetite. You take it as a once-weekly shot (usually in the belly, thigh, or upper arm). It was designed for type 2 diabetes, but the appetite reduction also causes weight loss, which is why it has gotten so much attention.
FDA Approval
Ozempic
Type 2 diabetes mellitus
0.25 mg, 0.5 mg, 1 mg, 2 mg weekly injection
How You Take It
The dose build-up helps reduce stomach side effects. Most people stay at 0.5 mg or 1 mg for diabetes. The 2 mg dose provides extra blood sugar and weight control but is not always needed.
How Much Weight You Can Lose
In diabetes trials, people on Ozempic 1 mg lost about 6% of their body weight, and those on 2 mg lost about 8%. That is less than Wegovy (about 15% at 2.4 mg) because Ozempic uses a lower maximum dose. If weight loss is your primary goal and you do not have diabetes, Wegovy or Zepbound will usually produce better results.
Blood sugar effect: Typical A1C drop of 1.0 to 1.8 points (bringing many patients from above 8% closer to the 7% target)
Side Effects
Common Side Effects
- Nausea (about 44% of users in the STEP 1 trial; usually worst during dose increases and eases after a few weeks)
- Diarrhea (about 32% of users; usually mild and short-lived)
- Vomiting (about 25% of users; tends to drop off after the first month or two)
- Constipation (about 23% of users; staying hydrated and adding fiber usually helps)
- Abdominal pain (about 20% of users; usually mild)
- Headache (about 14% of users)
- Fatigue (about 11% of users; often improves as your body adjusts)
- Injection site reactions (uncommon; mild redness or itching near the shot)
Rare but Serious
- Pancreatitis (rare)
- Gallbladder disease
- Thyroid C-cell tumors (boxed warning, observed in rodents)
- Hypoglycemia (when combined with insulin or sulfonylureas)
- Kidney injury (due to dehydration from GI effects)
- Allergic reactions
Managing side effects: Most stomach-related side effects show up during the first few weeks and during dose increases, then ease as your body adjusts. The slow dose build-up exists for this reason. Eating smaller meals, staying hydrated, and avoiding fatty or fried foods help a lot. If nausea is bad enough that you cannot keep food down, contact your provider. They can slow the dose escalation or pause it for a cycle.
Ozempic Cost & Savings (2026)
Savings programs: Ozempic Savings Card: commercially insured patients with type 2 diabetes can pay as little as $25/month for a 1, 2, or 3-month prescription. Medicare, Medicaid, and cash-paying patients are not eligible. NovoCare Patient Assistance Program may cover Ozempic for free for qualifying uninsured patients with type 2 diabetes who meet income requirements.
Who Should Not Take Ozempic
- Personal or family history of a type of thyroid cancer called medullary thyroid carcinoma (MTC)
- A rare condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Allergy to semaglutide or any ingredient in the medication
- Pregnancy or planning to become pregnant (stop at least 2 months before conception)
- History of inflamed pancreas (pancreatitis) — use with caution
Heart Health
In adults with type 2 diabetes and heart disease, Ozempic reduced major heart events by 26% compared to placebo over about 2 years. This led the FDA to add a heart-protection claim to Ozempic's label for people with both type 2 diabetes and cardiovascular disease.
What this means for you: If you have both type 2 diabetes and heart disease, Ozempic does double duty: it helps control your blood sugar and lowers your risk of heart attack and stroke. This heart benefit is one reason doctors prefer Ozempic over older diabetes medications.
What to Expect, Month by Month
Most patients notice decreased hunger and food cravings. Portion sizes naturally decrease.
Measurable weight loss begins as doses escalate. Average 2-4% body weight lost during escalation phase.
Maintenance dose reached. Consistent weight loss of 1-2 lbs per week. Most GI side effects have resolved.
Average 10-15% body weight lost. Blood pressure, cholesterol, and blood sugar improvements measurable.
Weight loss plateau at 15-17% average. Metabolic health markers stabilized. Maintenance phase begins.
Other Medications to Watch
Can cause dangerously low blood sugar when combined. Your doctor will likely reduce your insulin dose by 20 to 50% when starting semaglutide.
Because semaglutide slows digestion, pills you take by mouth may absorb differently. Take other oral medications at least 1 hour before your semaglutide injection day meals.
Slower digestion can change how warfarin absorbs. Your doctor should check your clotting levels (INR) more often when starting or changing your semaglutide dose.
Slower digestion could slightly reduce how well birth control pills absorb. Consider backup contraception during the first few months or switch to a non-oral method (patch, ring, IUD).
Special Situations
Do not use during pregnancy. Stop semaglutide at least 2 months before trying to conceive because it stays in your system for weeks. Animal studies showed harm to the fetus.
No dose change needed for mild or moderate kidney issues. If you have severe kidney disease, use with caution because the nausea and vomiting can cause dehydration, which makes kidney problems worse.
No dose change needed. Semaglutide is not processed by the liver.
No dose change needed. Clinical trials included people up to age 75. Older adults should watch for dehydration since stomach side effects can cause extra fluid loss.
Wegovy is FDA-approved for teens 12 and older with obesity. In the STEP TEENS trial, adolescents saw a 16.1% reduction in BMI. The dosing schedule is the same as for adults.
What Happens If You Stop
In the STEP 1 follow-up, people who stopped semaglutide after 68 weeks regained about two-thirds of the weight they had lost over the following year. Improvements in blood sugar, blood pressure, and cholesterol also partially reversed.
How to make stopping easier: Tapering your dose gradually (instead of stopping suddenly), building exercise habits while on the medication, working with a dietitian, and transitioning to a lower-cost maintenance plan can all reduce regain. Some doctors recommend staying on a low maintenance dose long-term.
Ozempic FAQs
No. Ozempic is only FDA-approved for type 2 diabetes and to reduce heart attack and stroke risk in adults with type 2 diabetes and heart disease. The same drug (semaglutide) is approved for weight loss, but it is sold as Wegovy at a higher maximum dose. Some doctors prescribe Ozempic off-label for weight loss, but insurance almost never covers off-label use. If your main reason for wanting a GLP-1 is weight loss and you do not have type 2 diabetes, ask your doctor about Wegovy or Zepbound instead.
The list price at retail pharmacies is about $997 per month for any dose (0.25 mg, 0.5 mg, 1 mg, or 2 mg). Novo Nordisk does not have a direct-to-consumer cash program for Ozempic the way they do for Wegovy. If you have no insurance and need a GLP-1 for weight loss, Wegovy through NovoCare ($499/month) or Zepbound through LillyDirect ($349 to $699/month) are typically much cheaper cash options.
If you have commercial insurance and a type 2 diabetes diagnosis, the Ozempic Savings Card lets you pay as little as $25 per month for a 1, 2, or 3-month prescription. Most commercial plans cover Ozempic for diabetes with prior authorization. Medicare Part D plans also cover it for diabetes, though cost-sharing varies. Medicare and Medicaid patients are not eligible for the savings card.
In clinical trials for diabetes, people on Ozempic 1 mg lost about 6% of their body weight on average, and those on 2 mg lost about 8%. That is less than Wegovy (about 15% at 2.4 mg) because Ozempic uses a lower maximum dose. If weight loss is your primary goal and you qualify, Wegovy or Zepbound will usually produce better results. Results vary a lot from person to person depending on dose, diet, exercise, and how your body responds.
Yes, for people with both type 2 diabetes and existing heart disease. The FDA expanded Ozempic's label in 2020 to include reducing the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease. This benefit was shown in the SUSTAIN-6 trial.
You need a prescription from a licensed doctor or nurse practitioner. You can get one in person or through a telehealth clinic. Many clinics specialize in GLP-1 prescribing and can handle the prior authorization paperwork your insurance usually requires. Use the directory below to compare clinics in your state.
The most common side effects are stomach-related: nausea, diarrhea, vomiting, constipation, and stomach pain. They usually show up when you first start or move up to a higher dose, and most people find they get better after a few weeks. Rare but more serious risks include inflammation of the pancreas, gallbladder problems, vision changes in people with diabetes, and a warning about thyroid tumors (seen in animal studies, not confirmed in humans). Always tell your doctor about your full medical history before starting.
Find Clinics Offering Ozempic
Compare Ozempic providers by pricing, telehealth availability, and patient ratings.
Search Ozempic Clinics →Related Ozempic resources
Find Ozempic Clinics by State
Ready to start Ozempic?
Search our directory of 3,323 GLP-1 clinics. Filter by medication, insurance, and telehealth availability.
Medical Disclaimer: This guide is for informational purposes only and is not medical advice. All clinical data is sourced from FDA prescribing information and published peer-reviewed trials. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or switching any medication.